1. [Home](https://www.g2.com/)
2. ...
3. [Data Science and Machine Learning Platforms](https://www.g2.com/categories/data-science-and-machine-learning-platforms)
4. [BenevolentAI AI-enabled drug discovery. Discussions](https://www.g2.com/products/benevolentai-ai-enabled-drug-discovery/discuss)

[
 ![Product Avatar Image](https://images.g2crowd.com/uploads/product/image/large_detail/large_detail_f729712af9bd0134c458f4d84979d925/benevolentai-ai-enabled-drug-discovery.png "Product Avatar Image")
](/products/benevolentai-ai-enabled-drug-discovery/reviews)

[

BenevolentAI AI-enabled drug discovery.

](/products/benevolentai-ai-enabled-drug-discovery/reviews)

0 ratings

BenevolentAI is a leading clinical-stage company that integrates artificial intelligence (AI) with scientific expertise to revolutionize drug discovery and development. By leveraging its proprietary Benevolent Platform™, the company uncovers novel biological insights, predicts new drug targets, and develops first-in-class or best-in-class therapeutics for complex diseases. This innovative approach aims to enhance the efficiency and success rates of bringing new medicines to patients. Key Features and Functionality: - AI-Driven Target Identification: Utilizes advanced AI tools to analyze vast datasets, identifying novel drug targets with higher precision. - Integrated Scientific Expertise: Combines AI capabilities with in-house scientific knowledge and wet-lab facilities to validate findings and accelerate drug development. - Collaborative Partnerships: Engages in strategic collaborations with pharmaceutical companies like AstraZeneca and Merck to co-develop innovative treatments. - Diverse Therapeutic Focus: Develops a broad pipeline addressing various complex diseases, including idiopathic pulmonary fibrosis, chronic kidney disease, systemic lupus erythematosus, and heart failure. Primary Value and Problem Solved: BenevolentAI addresses the challenges of traditional drug discovery, which often involve high costs, lengthy timelines, and low success rates. By integrating AI with scientific research, the company streamlines the identification of viable drug targets and accelerates the development process. This approach not only reduces the time and resources required to bring new therapies to market but also increases the likelihood of clinical success, ultimately delivering innovative medicines to patients more efficiently.

Show More

When users leave BenevolentAI AI-enabled drug discovery. reviews, G2 also collects common questions about the day-to-day use of BenevolentAI AI-enabled drug discovery.. These questions are then answered by our community of 850k professionals. Submit your question below and join in on the G2 Discussion.

* * *

### 0.0

Nps Score

### All BenevolentAI AI-enabled drug discovery. Discussions

Search

Most CommentedMost HelpfulPinned by G2Newest

All DiscussionsDiscussions with CommentsPinned by G2Discussions without Comments

FilterFilter

Filter byExpand/Collapse 

Sort by

Most Commented

Most Helpful

Pinned by G2

Newest

Filter by

All Discussions

Discussions with Comments

Pinned by G2

Discussions without Comments

Sorry...

There are no questions about BenevolentAI AI-enabled drug discovery. yet.

## Start a New Software Discussion

Have a software question?

Get answers from real users and experts

[Start A Discussion](/products/benevolentai-ai-enabled-drug-discovery/discussions/new)

* * *

 ![Product Avatar Image](https://images.g2crowd.com/uploads/product/image/thumb_square/thumb_square_f729712af9bd0134c458f4d84979d925/benevolentai-ai-enabled-drug-discovery.png "Product Avatar Image")

### Have you used BenevolentAI AI-enabled drug discovery. before?

Answer a few questions to help the BenevolentAI AI-enabled drug discovery. community

[
Yes
](javascript:void(0))[
Yes
](https://www.g2.com/authorize?form=signup&return_to=https%3A%2F%2Fwww.g2.com%2Fproducts%2Fbenevolentai-ai-enabled-drug-discovery%2Fdiscuss%3Fsmall_ask%3Dbenevolentai-ai-enabled-drug-discovery)
No